There are 3164 resources available
Introduction and scientific background
Presenter: Helen Gogas
Session: Why neoadjuvant immunotherapy is the future for melanoma
Resources:
Slides
Webcast
LBA73 - Tivozanib–nivolumab vs tivozanib monotherapy in patients with renal cell carcinoma (RCC) following 1 or 2 prior therapies including an immune checkpoint inhibitor (ICI): Results of the phase III TiNivo-2 study
Presenter: Toni Choueiri
Session: Proffered paper session 1: GU tumours, non-prostate
Resources:
Abstract
Slides
Webcast
G12C targeted therapies
Presenter: Natasha Leighl
Session: Treating KRAS-mutated NSCLC
Resources:
Slides
Webcast
Profiling the biology of CRC: Actionability and implementability
Presenter: Ryan Corcoran
Session: Metastatic colorectal cancer: Changing paradigms and the relevance for patient care
Resources:
Slides
Webcast
Hormone-receptor positive breast cancer
Presenter: Lucia Del Mastro
Session: New treatment algorithm in the treatment of metastatic breast cancer in 2024
Resources:
Slides
Webcast
Lessons from France's Cancer Barometers
Presenter: Jérôme Foucaud
Session: Improving the assessment of citizens perception of risk
Resources:
Webcast
Visiting the basics: Rationale and MoA
Presenter: Susana Banerjee
Session: Antibody drug conjugates (ADCs): Are there new therapeutic approaches in gynaecological cancers?
Resources:
Slides
Webcast
Introduction and scientific background
Presenter: Sebastian Amigorena
Session: Beyond coding neoantigens: What else is there for T cells to see?
Resources:
Webcast
Introduction and scientific background
Presenter: Anastasios Stathis
Session: New endpoints in early clinical trials
Resources:
Slides
Webcast
Introduction
Presenter: Sjoukje Oosting
Session: ESMO-MCBS: A practical tool with public health implications
Resources:
Slides
Webcast